2025 fourth_quarter Filing
Q4Lobbying Activities
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to pharmacy benefit management and drug pricing policies. Issues related to the Most Favored Nation drug pricing.
Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing.